Aptargroup Inc (ATR) Stock Analysis
Verdict: BUY
Resilient high-margin Pharma packaging provides a defensive floor, while the 46% gap to analyst fair value suggests a mispriced recovery play.
Investment score: 68/100
Analysis as of
Is Aptargroup Inc stock worth reviewing? The TradeMates thesis
Aptargroup is a high-quality packaging pure-play with pharmaceutical-grade margins. While insiders have been liquidating near $115-$123, the fundamental trajectory remains strong with 4/4 earnings beats and a healthy balance sheet (Current Ratio 1.66). The model targets a convergence toward the $150-$160 range within 90-180 days.
7-factor investment score
- Valuation: 60/100 (weight 20%)
- Financial Health: 85/100 (weight 15%)
- Technical Momentum: 55/100 (weight 15%)
- Earnings Quality: 75/100 (weight 15%)
- Insider Sentiment: 30/100 (weight 10%)
- Analyst Consensus: 80/100 (weight 10%)
- Risk-Adjusted Return: 70/100 (weight 15%)
Aptargroup Inc opportunities and risks
What speaks for ATR
- Pharma Segment Margin Expansion
What speaks against ATR
- Persistent Insider Selling Pressure
Peers and competitors
| Ticker | P/E | P/S | EV/EBITDA | Gross margin | Net margin | FCF yield |
|---|---|---|---|---|---|---|
| ATR | 21.7x | 2.1x | 11.2x | 29.0% | 10.0% | 4.0% |
| BALL | 18.3x | 1.2x | 11.3x | 15.7% | 6.9% | 3.5% |
| CCK | 18.2x | 1.0x | 9.0x | 18.0% | 5.6% | 7.6% |
| SLGN | 17.6x | 0.8x | 10.0x | 17.4% | 4.3% | 6.2% |
| GEF | 4.3x | 1.0x | 8.9x | 22.6% | 29.0% | -3.5% |
| OI | n/a | 0.2x | 8.7x | 16.0% | -2.9% | 2.5% |
| Peer median | 17.6x | 1.0x | 9.0x | 17.4% | 5.6% | 3.5% |
Frequently asked questions about Aptargroup Inc (ATR)
Is ATR stock a good investment?
The TradeMates model rates Aptargroup Inc as BUY with an investment score of 68/100. Aptargroup is a high-quality packaging pure-play with pharmaceutical-grade margins. While insiders have been liquidating near $115-$123, the fundamental trajectory remains strong with 4/4 earnings beats and a healthy balance sheet (Current Ratio 1.66). The model targets a convergence toward the $150-$160 range within 90-180 days. This is algorithmic model output, not personal investment advice.
Is ATR stock a buy?
The TradeMates model verdict for ATR is BUY with an investment score of 68/100. Treat this as a model signal to review, not a personal buy recommendation.